PT1128829E - Associacao de riluzole e de alfa-tocoferol - Google Patents

Associacao de riluzole e de alfa-tocoferol

Info

Publication number: PT1128829E
Authority: PT; Portugal
Prior art keywords: riluzole; associacao; tocoferol; alfa; combination
Prior art date: 1998-11-13

Application number

PT99972101T

Other languages

English (en)

Inventor

Michel Dib

Original Assignee

Aventis Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-13

Filing date

1999-11-09

Publication date

2005-07-29

1999-11-09 Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa

2005-07-29 Publication of PT1128829E publication Critical patent/PT1128829E/pt

Links

FTALBRSUTCGOEG-UHFFFAOYSA-N Riluzole Chemical compound C1=C(OC(F)(F)F)C=C2SC(N)=NC2=C1 FTALBRSUTCGOEG-UHFFFAOYSA-N 0.000 title abstract 3
229960004181 riluzole Drugs 0.000 title abstract 2
GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 abstract 2
239000002671 adjuvant Substances 0.000 abstract 1
229940087168 alpha tocopherol Drugs 0.000 abstract 1
239000003085 diluting agent Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
229960000984 tocofersolan Drugs 0.000 abstract 1
239000002076 α-tocopherol Substances 0.000 abstract 1
235000004835 α-tocopherol Nutrition 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Fats And Perfumes (AREA)
External Artificial Organs (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Anti-Oxidant Or Stabilizer Compositions (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Cosmetics (AREA)
Saccharide Compounds (AREA)
Treatment Of Liquids With Adsorbents In General (AREA)
Pyrane Compounds (AREA)

PT99972101T 1998-11-13 1999-11-09 Associacao de riluzole e de alfa-tocoferol PT1128829E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9814250A FR2785808B1 (fr)	1998-11-13	1998-11-13	Association riluzole et alpha-tocopherol

Publications (1)

Publication Number	Publication Date
PT1128829E true PT1128829E (pt)	2005-07-29

Family

ID=9532674

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT99972101T PT1128829E (pt)	1998-11-13	1999-11-09	Associacao de riluzole e de alfa-tocoferol

Country Status (23)

Country	Link
US (2)	US6642262B2 (pt)
EP (1)	EP1128829B1 (pt)
JP (1)	JP4693241B2 (pt)
KR (1)	KR100641472B1 (pt)
CN (1)	CN1177587C (pt)
AT (1)	ATE295168T1 (pt)
AU (1)	AU776242B2 (pt)
BR (1)	BR9915292A (pt)
CA (1)	CA2350671C (pt)
CZ (1)	CZ298808B6 (pt)
DE (1)	DE69925301T2 (pt)
DK (1)	DK1128829T3 (pt)
EA (1)	EA003671B1 (pt)
ES (1)	ES2239858T3 (pt)
FR (1)	FR2785808B1 (pt)
HK (1)	HK1041220B (pt)
HU (1)	HU226067B1 (pt)
IL (1)	IL142708A0 (pt)
NO (1)	NO328349B1 (pt)
PT (1)	PT1128829E (pt)
TR (1)	TR200101346T2 (pt)
WO (1)	WO2000028992A1 (pt)
ZA (1)	ZA200103810B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2786101B1 (fr) *	1998-11-24	2002-07-05	Aventis Laboratoire	Utilisation de la nicergoline dans le traitement de la spasticite
CA2625341A1 (en) *	2005-10-18	2007-04-26	Ono Pharmaceutical Co., Ltd.	Pharmaceutical for protection of motor nerve in patient with amyotrophic lateral sclerosis
US20070099156A1 (en) *	2005-10-28	2007-05-03	Jeff Wagner	Self-etching dental primer compositions and methods and systems utilizing such compositions
FR2957077B1 (fr)	2010-03-02	2012-04-13	Univ Dauvergne Clermont I	Utilisation du riluzole pour traiter ou prevenir les effets indesirables d'agents anti-cancereux
WO2014145776A2 (en) *	2013-03-15	2014-09-18	Baylor College Of Medicine	Msp and its receptors in the therapy of amyotrophic lateral sclerosis
CN114344297B (zh) *	2022-03-01	2024-05-14	暨南大学	利鲁唑在治疗少精症中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2688138B1 (fr) *	1992-03-06	1995-05-05	Rhone Poulenc Rorer Sa	Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la sclerose laterale amyotrophique.
US5843641A (en) *	1993-02-26	1998-12-01	Massachusetts Institute Of Technology	Methods for the daignosis, of familial amyotrophic lateral sclerosis
US6380252B1 (en) *	1996-07-05	2002-04-30	Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.	Use of L-acetylcarnitine, L-isovalerylcarnitine, L-propionylcarnitine for increasing the levels of IGF-1
US5780489A (en) *	1996-08-21	1998-07-14	Brooks; Benjamin Rix	Method for treating amyotrophic lateral sclerosis
JP3889844B2 (ja) *	1997-02-10	2007-03-07	龍兒梶	筋萎縮性側索硬化症治療剤
FR2782008B1 (fr) *	1998-08-07	2003-04-25	Sod Conseils Rech Applic	Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a traiter la sclerose laterale amyotrophique

1998
- 1998-11-13 FR FR9814250A patent/FR2785808B1/fr not_active Expired - Fee Related
1999
- 1999-11-09 JP JP2000582039A patent/JP4693241B2/ja not_active Expired - Fee Related
- 1999-11-09 PT PT99972101T patent/PT1128829E/pt unknown
- 1999-11-09 ES ES99972101T patent/ES2239858T3/es not_active Expired - Lifetime
- 1999-11-09 EP EP99972101A patent/EP1128829B1/fr not_active Expired - Lifetime
- 1999-11-09 CA CA2350671A patent/CA2350671C/fr not_active Expired - Fee Related
- 1999-11-09 BR BR9915292-4A patent/BR9915292A/pt not_active Application Discontinuation
- 1999-11-09 TR TR2001/01346T patent/TR200101346T2/xx unknown
- 1999-11-09 AT AT99972101T patent/ATE295168T1/de active
- 1999-11-09 DE DE69925301T patent/DE69925301T2/de not_active Expired - Lifetime
- 1999-11-09 WO PCT/FR1999/002753 patent/WO2000028992A1/fr not_active Ceased
- 1999-11-09 AU AU11655/00A patent/AU776242B2/en not_active Ceased
- 1999-11-09 DK DK99972101T patent/DK1128829T3/da active
- 1999-11-09 CN CNB998131903A patent/CN1177587C/zh not_active Expired - Fee Related
- 1999-11-09 HU HU0105301A patent/HU226067B1/hu not_active IP Right Cessation
- 1999-11-09 EA EA200100530A patent/EA003671B1/ru not_active IP Right Cessation
- 1999-11-09 HK HK02102998.6A patent/HK1041220B/zh not_active IP Right Cessation
- 1999-11-09 KR KR1020017005912A patent/KR100641472B1/ko not_active Expired - Fee Related
- 1999-11-09 CZ CZ20011561A patent/CZ298808B6/cs not_active IP Right Cessation
- 1999-11-09 IL IL14270899A patent/IL142708A0/xx not_active IP Right Cessation
2001
- 2001-05-10 ZA ZA200103810A patent/ZA200103810B/en unknown
- 2001-05-10 NO NO20012308A patent/NO328349B1/no not_active IP Right Cessation
- 2001-05-11 US US09/854,318 patent/US6642262B2/en not_active Expired - Lifetime
2003
- 2003-02-18 US US10/369,151 patent/US20030125363A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AU1165500A (en)	2000-06-05
ES2239858T3 (es)	2005-10-01
HU226067B1 (en)	2008-04-28
ATE295168T1 (de)	2005-05-15
NO328349B1 (no)	2010-02-01
CN1326348A (zh)	2001-12-12
AU776242B2 (en)	2004-09-02
IL142708A0 (en)	2002-03-10
EP1128829A1 (fr)	2001-09-05
CZ20011561A3 (cs)	2001-08-15
NO20012308L (no)	2001-05-10
BR9915292A (pt)	2001-08-07
TR200101346T2 (tr)	2002-05-21
FR2785808B1 (fr)	2002-12-06
HK1041220A1 (en)	2002-07-05
US6642262B2 (en)	2003-11-04
DK1128829T3 (da)	2005-08-29
US20030125363A1 (en)	2003-07-03
HK1041220B (zh)	2005-07-22
KR20010080407A (ko)	2001-08-22
HUP0105301A2 (hu)	2002-05-29
EP1128829B1 (fr)	2005-05-11
JP2002529506A (ja)	2002-09-10
NO20012308D0 (no)	2001-05-10
WO2000028992A1 (fr)	2000-05-25
JP4693241B2 (ja)	2011-06-01
EA003671B1 (ru)	2003-08-28
US20020019426A1 (en)	2002-02-14
KR100641472B1 (ko)	2006-10-31
FR2785808A1 (fr)	2000-05-19
HUP0105301A3 (en)	2006-07-28
CN1177587C (zh)	2004-12-01
CA2350671C (fr)	2010-05-04
ZA200103810B (en)	2002-08-12
CZ298808B6 (cs)	2008-02-06
DE69925301T2 (de)	2006-01-26
DE69925301D1 (de)	2005-06-16
CA2350671A1 (fr)	2000-05-25
EA200100530A1 (ru)	2001-10-22

Publication	Publication Date	Title
DK1214936T3 (da)	2004-12-06	Anvendelse af thiazolidin- eller pyrrolidinderivater af aminosyrer som antihyperglykæmiske midler
ES2114487B1 (es)	1999-04-01	Mezcla estabilizante sinergistica.
DK0797439T3 (da)	2003-08-25	Anvendelse af pramipexol som et neurobeskyttende middel
BR0215405A (pt)	2005-01-25	Composições e processos de uso de collajolie
ES2138691T3 (es)	2000-01-16	Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
ITRM940150A0 (it)	1994-03-18	Procedimento per il trattamento di acque di scarico fortemente colorate.
ES2091068T3 (es)	1996-10-16	Combinaciones de productos activos fungicidas.
DK1336605T3 (da)	2006-06-19	Substituerede phenolderivater eller salte deraf som inhibitorer af koagulationsfaktor X
TR199701654T1 (xx)	1998-05-21	4-Fenilaminotiyazol t�revleri.
EA200100208A1 (ru)	2001-08-27	Новая форма соли пантопразола
FR2848116B1 (fr)	2007-01-05	Composition cosmetique comprenant un inhibiteur des metallo-proteinases et un lipopeptide.
PT1119359E (pt)	2004-08-31	Formulacao de 2-metil-tieno-benzodiazepina
BR9608594B1 (pt)	2010-07-27	misturas de benzimidazóis substituìdos para o combate de protozoários parasìticos.
PT1128829E (pt)	2005-07-29	Associacao de riluzole e de alfa-tocoferol
IS5951A (is)	2001-05-22	5HT1 mótlyf fyrir meðferð gegn þunglyndi
DK0941975T3 (da)	2002-04-22	Injiceringscement indeholdende korrosionshæmmere
AU2002218337A1 (en)	2002-06-11	Method for inducing cognition enhancement by use of trimethyl-bicyclo(2.2.1)heptane derivatives
DK1073447T3 (da)	2007-09-03	N1-modificerede glycopeptider
BR0112460A (pt)	2003-07-22	Método para tratamento de sépsis
ITRM910216A0 (it)	1991-04-02	Procedimento per la preparazione di composti amminici aromatici e relativo agente riducente. (caso 156-7123)
FR2778102B1 (fr)	2001-04-06	Utilisation d'oligomeres procyanidoliques (opc) ou d'anthocyanosides a titre d'agents anti-urease
SE9303060D0 (sv)	1993-09-19	Löstagbar stoppanordning
FR2765795B1 (fr)	2000-02-11	Systeme d'osteosynthese, notamment du grand trochanter
IT1303825B1 (it)	2001-02-23	Corredo di strumenti per microchirurgia oftalmica.
ECSP972052A (es)	1998-02-13	Quinoxalinadionas